Faculty of Health Sciences
School of Medicine
Department of Medical Oncology
Rapoport, BL
MD (Argentina) MMed(Int)(Witwatersrand) - Lecturer/Specialist
Contact Details
Research Interests
Research Output
Contact Details:
Telephone number: 011 880 4169
Fax number: 011 880 4363
Research Interests:
Medical oncology
Research Output:
Research articles in refereed specialist journals:
Biganzoli L, Cufer T, Bruning P, Coleman RE, Duchateau L, Rapoport BL, Nooij M, Delhaye F, Miles D, Sulkes A, Hamilton A, Piccart M: 2003. Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial. Cancer, 97 (1) / Jan, pp 40-45.
Vorobiof DA, Rapoport BL, Chasen MR, Cohen GL, Mahomed R, Karime M: 2003. Phase II clinical trial of carboplatin and docetaxel in patients with metastataic ovarian cancer: Active combination with low incidence of peripheral neuropathy. International Journal of Gynecological Cancer, 13 (3) / May/Jun, pp 287-291.
de Wit R, Herrstedt J, Rapoport BL, Carides AD, Carides G, Elmer M, Schmidt C, Evans JK, Horgan KJ: 2003. Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology, 21 (22) / Nov, pp 4105-4111.
Vorobiof DA, Rapoport BL, Mahomed R, Karime M: 2003. Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment. Melanoma Research, 13 (2) / April, pp 201-203.
Abratt RP, Eele R, Goedhals L, Rapoport BL, Slabber CF, Vorobiof DA: 2003. Guidelines for CPD Accreditation of the South African Society of Medical Oncology. South African Medical Journal, 93 (10) / Oct, p. 728.
|
